Clinical Trial Update: A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of the TB drug candidate TBI-223 in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• TBI-223

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Tuberculosis, Tuberculosis, Pulmonary | Phase 1 | Status: COMPLETED | Results posted: 2024-12-09